4-81046085-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001201.5(BMP3):āc.664A>Gā(p.Thr222Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000738 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T222M) has been classified as Likely benign.
Frequency
Consequence
NM_001201.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 94AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000586 AC: 147AN: 250756Hom.: 0 AF XY: 0.000664 AC XY: 90AN XY: 135478
GnomAD4 exome AF: 0.000750 AC: 1097AN: 1461842Hom.: 0 Cov.: 34 AF XY: 0.000759 AC XY: 552AN XY: 727220
GnomAD4 genome AF: 0.000617 AC: 94AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.664A>G (p.T222A) alteration is located in exon 2 (coding exon 2) of the BMP3 gene. This alteration results from a A to G substitution at nucleotide position 664, causing the threonine (T) at amino acid position 222 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at